{"database": "openregs", "table": "documents", "rows": [["FDA-1996-D-0048-0005", "FDA", "FDA-1996-D-0048", "Q3B(R) Impurities in New Drug Products (Revision 2)", "Other", "Guidance", "2006-08-04T04:00:00Z", 2006, 8, "2020-06-02T04:00:00Z", null, "2024-11-15T02:00:46Z", null, 1, 0, "09000064846c4e6f"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-1996-D-0048-0005"], "units": {}, "query_ms": 91.66905598249286, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}